Cagrilintide is a long-acting, acylated derivative of amylin that exhibits agonistic properties on both natural amylin and calcitonin receptors and has been studied for weight control purposes. It targets the glucagon receptor (GCGR) to enhance the feeling of fullness (satiety) and decrease food cravings.Description
🧬 Cagrilintide
🧬 CagrilintideAvailable Variation: 5mg, 10mg
Cagrilintide is a long-acting, acylated research peptide derived from amylin, designed to exhibit agonistic activity at amylin and calcitonin receptors. In experimental settings, it has been studied for its role in appetite regulation, satiety signaling, and energy intake modulation.
Research models indicate that Cagrilintide interacts with central and peripheral pathways involved in hunger signaling and food intake behavior. Its extended activity profile makes it a subject of interest in metabolic and endocrine research focused on appetite control mechanisms.
Key research areas include:
-
Appetite and satiety signaling
-
Amylin and calcitonin receptor pathways
-
Metabolic and endocrine regulation
-
Energy balance research models
Cagrilintide from Johnson Peptides is manufactured for laboratory research and analytical use only.
Product Specifications
-
Peptide Type: Synthetic Research Peptide
-
Form: Lyophilized Powder
-
Purity: ≥98% (HPLC verified)
-
Application: Research & Laboratory Use Only
